OptimizeRx (OPRX) Gross Margin (2013 - 2026)

OptimizeRx (OPRX) posted Gross Margin of 75.25% for Q1 2026, up 0.66% sequentially from 74.75% in Q4 2025, and up 1439.0% YoY from 4.89% in Q1 2025.

OptimizeRx (OPRX) Gross Margin (2013 - 2026) Analysis & Trends

OptimizeRx has reported Gross Margin for 14 years, with the latest figure at 75.25% in Q1 2026.

Quarterly Gross Margin rose 1439.0% year-over-year to 75.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 70.04% (up 591.0% YoY) and the FY2025 annual result came in at 67.25%, up 280.0% from the prior year.
Gross Margin climbed to 75.25% in Q1 2026 per OPRX's latest filing, from 74.75% in the prior quarter.
Over five years, Gross Margin peaked at 75.25% in Q1 2026 and troughed at 56.63% in Q2 2023.
A 5-year average of 63.71% and a median of 62.89% in 2023 frame the typical range for Gross Margin.
The sharpest annual moves came in 2023 and 2026: Gross Margin tumbled 768 bps in 2023, then surged 1439 bps in 2026.
Over 5 years, Gross Margin stood at 63.37% in 2022, then decreased by 1 bps to 62.89% in 2023, then rose by 8 bps to 68.15% in 2024, then climbed by 10 bps to 74.75% in 2025, then gained by 1 bps to 75.25% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 75.25%, 74.75%, and 67.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	74.98%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	12.72%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	72.27%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	74.48%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	86.44%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	57.35%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	69.44%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	84.87%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	83.00%
10	OptimizeRx	164.25 Mn	140.15 Mn	15.69 Mn	76.51%

Download Data